Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean Publisher Pubmed



Alahmari AD1 ; Aljurf M1 ; Alseraihy A2 ; Hamidieh AA3 ; Alkindi S4 ; Rihani R5 ; Satti T6 ; Jastaniah W7 ; Alsaedi H2 ; Almohareb F1 ; Aljefri A2 ; Rasheed W1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Adult Hematology/Bone Marrow Transplantation, Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  2. 2. Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  3. 3. Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman
  5. 5. King Hussein Cancer Center, Amman, Jordan
  6. 6. Armed Forces Bone Marrow Transplant Centre National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan
  7. 7. College of Medicine, Department of Pediatrics, Umm AlQura University, Makkah, Saudi Arabia

Source: Hematology/ Oncology and Stem Cell Therapy Published:2020


Abstract

[No abstract available]
Related Docs
1. Applied Stem Cell Research in Sickle Cell Disease, Comprehensive Hematology and Stem Cell Research: Volume 1-5 (2024)
Experts (# of related papers)